Whole-Body Scintigraphy and Quantitative SPECT/CT Using the PSMA-Agent Tc-99m-MIP-1404 in the Preoperative Staging of Prostate Cancer - Preliminary Results

被引:0
|
作者
Beck, Michael [1 ]
Reinfelder, Julia [1 ]
Ritt, Philipp [1 ]
Sanders, James [2 ]
Torsten, Kuwert [1 ]
机构
[1] Clin Nucl Med, Erlangen, Germany
[2] Univ Hosp Erlangen, Erlangen, Germany
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
1545
引用
收藏
页数:2
相关论文
共 24 条
  • [1] The PSMA-Agent Tc-99m-MIP-1404 in the Primary Staging of Biopsy Proven Prostate Cancer - Preliminary Results
    Beck, M.
    Reinfelder, J.
    Ritt, P.
    Sanders, J.
    Bartschat, T.
    Goebell, P.
    Kuwert, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S346 - S346
  • [2] SPECT/CT with the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients with Prostate Cancer
    Schmidkonz, Christian
    Cordes, Michael
    Beck, Michael
    Goetz, Theresa
    Schmidt, Daniela
    Prante, Olaf
    Bauerle, Tobias
    Uder, Michael
    Wullich, Bernd
    Goebell, Peter
    Kuwert, Torsten
    Ritt, Philipp
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [3] SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer
    Schmidkonz, Christian
    Cordes, Michael
    Beck, Michael
    Goetz, Theresa Ida
    Schmidt, Daniela
    Prante, Olaf
    Baeuerle, Tobias
    Uder, Michael
    Wullich, Bernd
    Goebell, Peter
    Kuwert, Torsten
    Ritt, Philipp
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (04) : 225 - 231
  • [4] Radioimpurity profile of Tc-99m-MIP-1404, a single amino acid chelate derived inhibitor of prostate specific membrane antigen (PSMA) for imaging prostate cancer
    Maresca, Kevin
    Wang, Jian Cheng
    Hillier, Shawn
    Marquis, John
    Zimmerman, Craig
    Kronauge, James
    Eckelman, William
    Joyal, John
    Babich, John
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [5] 99mTc-MIP-1404 SPECT/CT for Assessment of Whole-Body Tumor Burden and Treatment Response in Patients With Biochemical Recurrence of Prostate Cancer
    Schmidkonz, Christian
    Goetz, Theresa Ida
    Atzinger, Armin
    Ritt, Philipp
    OlafPrante
    Kuwert, Torsten
    Baeuerle, Tobias
    Goebell, Peter
    Cordes, Michael
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (08) : E349 - E357
  • [6] Development of a simple kit for Tc-99m-MIP-1404, a single amino acid chelate (SAAC II) derived small molecule inhibitor of prostate specific membrane antigen (PSMA) for imaging prostate cancer
    Maresca, Kevin
    Wang, Jian Cheng
    Hillier, Shawn
    Femia, Frank
    Lu, Genliang
    Zimmerman, Craig
    Kronauge, James
    Eckelman, William
    Joyal, John
    Babich, John
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [7] Comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and 99mTc-HMDP SPECT/CT to planar bone scintigraphy and CT in primary staging of intermediate or high-risk prostate cancer
    Malaspina, S.
    Anttinen, M.
    Ettala, O.
    Jambor, I.
    Kemppainen, J.
    Sandell, M.
    Rinta-Kiikka, I.
    Kajander, S.
    Schildt, J.
    Saukko, E.
    Timonen, K.
    Rautio, P.
    Noponen, T.
    Saunavaara, J.
    Aronen, H.
    Seppanen, M.
    Bostrom, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S293 - S293
  • [8] DEEP LEARNING ALGORITHM IMPROVES IDENTIFICATION OF MEN WITH LOW RISK PROSTATE CANCER USING PSMA-TARGETED 99MTC-MIP-1404 SPECT/CT
    Meyer, Alexa
    Stambler, Nancy
    Sjostrand, Karl
    Richter, Jens
    Allaf, Mohamad
    Rowe, Steven
    Wong, Vivien
    Anand, Aseem
    Gorin, Michael
    JOURNAL OF UROLOGY, 2020, 203 : E1195 - E1196
  • [9] Whole-body lesion detection and prostate cancer staging in 68Ga-PSMA-11 PET/CT using deep learning
    Capobianco, N.
    Gafita, A.
    Platsch, G.
    Sibille, L.
    Spottiswoode, B.
    Eiber, M.
    Weber, W. A.
    Navab, N.
    Nekolla, S. G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S273 - S274
  • [10] Deep learning algorithm improves identification of men with low-risk prostate cancer using PSMA-targeted 99mTc-MIP-1404 SPECT/CT.
    Meyer, Alexa
    Stambler, Nancy
    Sjostrand, Karl
    Richter, Jens
    Allaf, Mohamad
    Rowe, Steven P.
    Wong, Vivien
    Anand, Aseem
    Gorin, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)